CARY, NC – Trana Discovery Inc., an infectious disease drug discovery technology company, has formed a Scientific Advisory Board that will advise the company on the needs of the infectious disease community and on the development of assays to discover new medicines for the treatment of serious bacterial, viral, and fungal infectious diseases.  More information…

By Allan Maurer
CARY, NC—Trana Discovery, a biotech startup out of North Carolina State University and the Technical University of Lodz, Poland, has developed a new patented technology that may help defeat a wide range of infectious diseases, including antibiotic resistant staph and the wily AIDS virus. More information…

Drug discovery startup Trana Discovery plans to commercialize high-throughput test technology that it says could lead to development of anti-infectives targeting staph bacteria.  More information…

Trana Discovery has developed a test that can select compounds that demonstrate anti-HIV bioactivity, the drug discovery technology firm said Tuesday. More information…

CARY, N.C. – Trana Discovery Inc. and Southern Research Institute have announced a collaborative research agreement that could lead to the discovery of new classes of drugs for the treatment of patients infected with HIV. Under the agreement, Trana will screen Southern Research’s library of approximately 1000 nucleosides against its unique, patented probes to identify anti-infectives with a novel mechanism of action.  More ...

Southern Research Institute has entered into a collaborative research agreement  with a North Carolina drug discovery company targeting the creation of new HIV  treatments.

Read more:  Southern Research joins with N.C. firm to pursue new AIDS treatments | Birmingham Business Journal

CARY, N.C. — Trana Discovery, a drug discovery firm based in Cary, and the Southern Research Institute have agreed to work together to seek potential drugs for the treatment of AIDS. More information…

CARY, N.C.—After nearly 20 years of study and research into the delicate structure and mechanism of transfer RNA (tRNA), the former Neos Discovery has taken on a new name to more accurately reflect its area of expertise – Trana Discovery—and has also brought on board five former Glaxo executives to commercialize the company’s technology. Read more…

CARY, N.C. — Five former executives at Glaxo are joining forces to re-launch a Cary-based drug discovery company.

Led by Steve Peterson who takes over as chief executive officer, the company has changed its name to Trana Discovery from Neos Discovery. The firm has also secured an unnamed investor who is providing an undisclosed amount of financing. Read more…